GC Biopharma Corp. (KRX: 006280)
South Korea
· Delayed Price · Currency is KRW
138,600
-1,500 (-1.07%)
Nov 15, 2024, 3:30 PM KST
GC Biopharma Revenue
GC Biopharma had revenue of 417.36B KRW in the quarter ending June 30, 2024, a decrease of -3.58%. This brings the company's revenue in the last twelve months to 1.62T, down -2.12% year-over-year. In the year 2023, GC Biopharma had annual revenue of 1.63T, down -4.95%.
Revenue (ttm)
1,618.47B
Revenue Growth
-2.12%
P/S Ratio
0.92
Revenue / Employee
802.81M
Employees
2,016
Market Cap
1,493.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,626.64B | -84.67B | -4.95% |
Dec 31, 2022 | 1,711.31B | 173.49B | 11.28% |
Dec 31, 2021 | 1,537.83B | 33.71B | 2.24% |
Dec 31, 2020 | 1,504.12B | 147.00B | 10.83% |
Dec 31, 2019 | 1,357.12B | 22.24B | 1.67% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition